Infections in systemic lupus erythematosus

Area of Science:

• Immunology
• Infectious Diseases
• Rheumatology

Background:

• Infections significantly increase morbidity and mortality in systemic lupus erythematosus (SLE) patients.
• SLE patients in developing countries experience lower survival rates due to infection and active disease.
• Infectious agents can trigger lupus expression and activity, complicating disease management.

Purpose of the Study:

• To highlight the critical role of infections in SLE outcomes.
• To underscore the disparities in SLE patient survival between industrialized and developing countries.
• To emphasize the dual impact of infections: increasing susceptibility and triggering disease activity.

Main Methods:

• Literature review on infection-related outcomes in SLE.
• Comparative analysis of survival rates in different global regions.
• Examination of the interplay between immunosuppression, infection, and lupus activity.

Main Results:

• Infections are a primary cause of death in SLE, particularly in developing nations.
• Lower survival rates in developing countries are linked to infection and disease activity.
• Endemic infections like tuberculosis present unique challenges in these regions.

Conclusions:

• Addressing infection risks is crucial for improving SLE patient survival globally.
• Targeted strategies are needed to manage infections in SLE patients, especially in resource-limited settings.
• Understanding the infection-SLE nexus is vital for effective lupus management and public health initiatives.